Atlas Trials

Second STOP After Pioglitazone Priming in CML Patients

Clinical trial NCT02889003 · RECRUITING

Trial details

NCT number
NCT02889003
Sponsor
Versailles Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia (CML)
Start date
2016-12-01
Primary completion
2027-12-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.